Alfred Kaye, MD, PhD
Assistant Professor of PsychiatryCards
Appointments
About
Copy Link
Titles
Assistant Professor of Psychiatry
Biography
Dr. Kaye is an Assistant Professor of Psychiatry, using a combination of circuit and computational approaches to understand adaptations to the danger in the environment and how those adaptations underlie PTSD. He graduated from the University of California M.D., Ph.D. program, where he used two-photon imaging and computational modeling to understand the organization of visual motion processing. Then, he joined the psychiatry residency at Yale, where he worked in Alex Kwan's lab on using calcium and neurotransmitter imaging to understand how arousal states change after stress, and also developed computational models of PTSD.
The lab will focus on understanding how neuromodulatory circuits reprogram one another to create adaptive responses to traumatic experiences. Underlying this idea is the central problem of developing a mechanistic and functional understanding of stress and anxiety. The lab uses microendoscope and two-photon imaging of calcium and neurotransmitter sensors, large-scale electrophysiology (Neuropixels), computational analysis of behavior (DeepLabCut), and single cell transcriptomics to understand this problem.
Appointments
Psychiatry
Assistant ProfessorPrimary
Other Departments & Organizations
- Center for Brain & Mind Health
- Damisah Lab
- Division of Molecular Psychiatry
- Interdepartmental Neuroscience Program
- Janeway Society
- Neuroscience Research Training Program (NRTP)
- Neuroscience Track
- Psychiatry
- Swartz Program in Theoretical Neurobiology
- Wu Tsai Institute
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
Education & Training
- Research Fellow
- Veterans Administration National Center for PTSD (2020)
- Non Degree Program
- VA National Center for PTSD, Research Fellow (2020)
- Resident
- Yale University (2018)
- Chief Resident
- Yale University (2018)
- MD
- University of California, San Diego (2014)
- PhD
- University of California, San Diego (2013)
Board Certifications
Psychiatry
- Certification Organization
- ABPN
- Original Certification Date
- 2021
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0002-3153-1221
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
John Krystal, MD
Alex Kwan, PhD
Christopher Pittenger, MD, PhD
Benjamin Kelmendi, MD
Clara Liao, BA
Neil K. Savalia
Norepinephrine
Publications
2026
α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice
Rosado A, Yu A, Yang J, Rondeau J, Floris G, Basu A, Staszko S, Dibbs M, Feng J, Li Y, Warner-Schmidt J, Kelmendi B, Krystal J, Pittenger C, Kwan A, Kaye A. α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice. Molecular Psychiatry 2026, 1-12. PMID: 42414551, DOI: 10.1038/s41380-026-03713-1.Peer-Reviewed Original ResearchAltmetricAstrocytes in predictive processing of emotion: Kir4.1 as precision modulator of social interaction
Basu A, Kaye A. Astrocytes in predictive processing of emotion: Kir4.1 as precision modulator of social interaction. Acta Pharmaceutica Sinica B 2026, 16: 2595-2597. PMID: 42039284, PMCID: PMC13104678, DOI: 10.1016/j.apsb.2026.03.043.Commentaries, Editorials and LettersAltmetricModulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies
Costa G, Cerezo-Matias M, Funaro M, Bagdas D, Kaye A, Krystal J, Petrakis I, De Aquino J. Modulating the endocannabinoid system in alcohol use disorder: A translational systematic review and meta-analysis of preclinical and human studies. Molecular Psychiatry 2026, 31: 3849-3871. PMID: 41760917, PMCID: PMC13269127, DOI: 10.1038/s41380-026-03523-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThis study investigates targeting the endocannabinoid system for alcohol use disorder, finding promising preclinical results for cannabidiol and CB1 receptor modulators, but inconsistent human trial outcomes highlight the need for better-designed clinical studies.
2025
Frontal noradrenergic and cholinergic transients exhibit distinct spatiotemporal dynamics during competitive decision-making
Wang H, Ortega H, Kelly E, Indajang J, Savalia N, Glaeser-Khan S, Feng J, Li Y, Kaye A, Kwan A. Frontal noradrenergic and cholinergic transients exhibit distinct spatiotemporal dynamics during competitive decision-making. Science Advances 2025, 11: eadr9916. PMID: 40138407, PMCID: PMC11939063, DOI: 10.1126/sciadv.adr9916.Peer-Reviewed Original ResearchCitationsClassification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression
Aboharb F, Davoudian P, Shao L, Liao C, Rzepka G, Wojtasiewicz C, Indajang J, Dibbs M, Rondeau J, Sherwood A, Kaye A, Kwan A. Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression. Nature Communications 2025, 16: 1590. PMID: 39939591, PMCID: PMC11822132, DOI: 10.1038/s41467-025-56850-6.Peer-Reviewed Original ResearchCitationsAltmetricNovel Approaches for Treating Anxiety and Trauma-Related Disorders
Kaye A, Jefferson S, Krystal J. Novel Approaches for Treating Anxiety and Trauma-Related Disorders. 2025, 583-598. DOI: 10.1093/med/9780197640654.003.0043.Books
2024
Xylazine induces dopamine release and augments the effects of fentanyl
Trinko J, Foscue E, Kong E, Basu A, Corstens A, Thompson S, Kaye A, Taylor J, DiLeone R. Xylazine induces dopamine release and augments the effects of fentanyl. Journal Of Clinical Investigation 2024, 134: e183354. PMID: 39545408, PMCID: PMC11563672, DOI: 10.1172/jci183354.Peer-Reviewed Original ResearchCitationsAltmetricThe human claustrum tracks slow waves during sleep
Lamsam L, Gu B, Liang M, Sun G, Khan K, Sheth K, Hirsch L, Pittenger C, Kaye A, Krystal J, Damisah E. The human claustrum tracks slow waves during sleep. Nature Communications 2024, 15: 8964. PMID: 39419999, PMCID: PMC11487173, DOI: 10.1038/s41467-024-53477-x.Peer-Reviewed Original ResearchCitationsAltmetricSpatiotemporal Organization of Prefrontal Norepinephrine Influences Neuronal Activity
Glaeser-Khan S, Savalia N, Cressy J, Feng J, Li Y, Kwan A, Kaye A. Spatiotemporal Organization of Prefrontal Norepinephrine Influences Neuronal Activity. ENeuro 2024, 11: eneuro.0252-23.2024. PMID: 38702188, PMCID: PMC11134306, DOI: 10.1523/eneuro.0252-23.2024.Peer-Reviewed Original ResearchCitationsAltmetricFrontal Norepinephrine Represents a Threat Prediction Error Under Uncertainty
Basu A, Yang J, Yu A, Glaeser-Khan S, Rondeau J, Feng J, Krystal J, Li Y, Kaye A. Frontal Norepinephrine Represents a Threat Prediction Error Under Uncertainty. Biological Psychiatry 2024, 96: 256-267. PMID: 38316333, PMCID: PMC11269024, DOI: 10.1016/j.biopsych.2024.01.025.Peer-Reviewed Original ResearchCitationsAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity National Science Foundation
2021 - 2022Peer Review Groups and Grant Study SectionsAd-hoc reviewer
Honors
honor Pilot Grant Research Award
08/26/2020Yale University Award10X GenomicsDetailsUnited Stateshonor Mentored Clinical Scientist Research Career Development Award (K08)
08/26/2020National AwardNational Institute of Mental HealthDetailsUnited Stateshonor The Seymour L. Lustman Award for Psychiatric Research
05/15/2019Yale School of Medicine AwardYale UniversityDetailsUnited Stateshonor NARSD Young Investigator Award
01/01/2019National AwardBrain and Behavior Research FoundationDetailsUnited Stateshonor Outstanding Resident Award Program
06/14/2017National AwardNational Institute of Mental HealthDetailsUnited States
News
Copy Link
News
- February 27, 2026Source: Molecular Psychiatry
Modulating the Endocannabinoid System in Alcohol Use Disorder: A Translational Systematic Review and Meta-Analysis of Preclinical and Human Studies
- September 18, 2025
Yale Scientists Seek to Uncover Neural and Genomic Mechanisms that Drive Anxiety
- January 17, 2025
Antoneta Gavoci and Stephanie Staszko Receive 2025 Kavli Postdoctoral Award for Academic Diversity
- November 25, 2024
Yale Center for the Science of Cannabis and Cannabinoids Announces Inaugural Pilot Award Winners